Dudediligence.

Aligos Therapeutics, Inc

ALGSNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Sep 158-KMaterial agreement1.01
  2. Aug 610-QQuarterly report
  3. Aug 68-KResults of operations2.029.01
  4. Jun 268-KOfficer or director change and shareholder vote5.025.079.01
  5. May 710-QQuarterly report
  6. May 78-KResults of operations2.029.01
  7. Apr 218-KMaterial agreement1.01
  8. Apr 148-KOther events8.019.01
  9. Mar 510-KAnnual report
  10. Mar 58-KResults of operations2.029.01
  11. Feb 48-KOfficer or director change5.02
  12. Nov 6, 202510-QQuarterly report
  13. Nov 6, 20258-KResults of operations2.029.01
  14. Aug 6, 202510-QQuarterly report
  15. Aug 6, 20258-KResults of operations2.029.01
  16. Jun 26, 20258-KOfficer or director change and bylaws or fiscal year changed5.025.035.079.01
  17. May 6, 202510-QQuarterly report
  18. May 6, 20258-KResults of operations2.029.01
  19. Apr 3, 2025424B3Prospectus for an offering
  20. Mar 27, 2025S-3Shelf registration
  21. Mar 10, 202510-KAnnual report
  22. Mar 10, 20258-KResults of operations2.029.01
  23. Feb 12, 20258-KMaterial agreement and unregistered sale of shares1.013.027.019.01
  24. Feb 3, 20258-KOfficer or director change5.02
  25. Nov 6, 2024S-3Shelf registration
  26. Nov 6, 202410-QQuarterly report
  27. Nov 6, 20248-KResults of operations2.029.01